European Journal of Clinical Investigation

CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?
pp. 1033-1035(3)
Authors: Rosner, M.; Dolznig, H.; Fuchs, C.; Siegel, N.; Valli, A.; Hengstschläger, M.

Cardiovascular risk factors and collateral artery formation
pp. 1036-1047(12)
Authors: de Groot, D.; Pasterkamp, G.; Hoefer, I. E.

Antegrade flow and peripheral resistance determine the level of endogenous arteriogenesis in patients with superficial femoral artery occlusion
pp. 1048-1054(7)
Authors: Vajanto, I.; Korpisalo, P.; Karjalainen, J.; Hakala, T.; Mäkinen, K.; Ylä-Herttuala, S.

Fat distribution influences the cardio-metabolic profile in a clinically healthy European population
pp. 1055-1064(10)
Authors: Bobbioni-Harsch, E.; Pataky, Z.; Makoundou, V.; Kozakova, M.; Dekker, J.; Golay, A.

High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis
pp. 1065-1072(8)
Authors: Basta, G.; Castagnini, M.; Del Turco, S.; Epistolato, M. C.; Righini, P.; Sangiorgi, G. M.; De Caterina, R.; Tanganelli, P.

Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment
pp. 1073-1081(9)
Authors: Adlbrecht, C.; Hülsmann, M.; Gwechenberger, M.; Strunk, G.; Khazen, C.; Wiesbauer, F.; Elhenicky, M.; Neuhold, S.; Binder, T.; Maurer, G.; Lang, I. M.; Pacher, R.

MMP/ TIMP balance is modulated in vitro by 15dPGJ₂ in fetuses and placentas from diabetic rats
pp. 1082-1090(9)
Authors: Pustovrh, M. C.; Capobianco, E.; Martínez, N.; Higa, R.; White, V.; Jawerbaum, A.

Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients
pp. 1091-1097(7)
Authors: Scarpato, R.; Tusa, I.; Antonelli, A.; Fallhai, P.; Sbrana, I.

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
pp. 1098-1109(12)
Authors: Sillaber, C.; Herrmann, H.; Bennett, K.; Rix, U.; Baumgartner, C.; Böhm, A.; Herndlhofer, S.; Tschachler, E.; Superti-Furga, G.; Jäger, U.; Valent, P.

Acquired Glanzmann's thrombasthenia associated with Hairy cell leukaemia
pp. 1110-1111(2)
Authors: Kannan, M.; Chatterjee, T.; Ahmad, F.; Kumar, R.; Choudhry, V. P.; Saxena, R.

Comorbidity, iron overload and HFE variants: a new prognostic complex in MDS?
pp. 1112-1113(2)
Authors: Valent, P.; Sperr, W. R.; Födinger, M.; Kundi, M.

Corrigendum
pp. 1114-1114(1)